Lyra Therapeutics, Inc. (LYRA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 16.27M | 23.02M | 31.06M | 33.91M | 43.02M | 54.44M | 69.44M | 89.44M | 104.82M | 104.92M | 118.25M | 84.8M |
| Cash & Short-Term Investments | 15.89M | 22.05M | 29.78M | 31.73M | 40.58M | 51.63M | 67.5M | 87.12M | 102.75M | 102.55M | 116.15M | 82.71M |
| Cash Only | 15.89M | 22.05M | 29.78M | 31.73M | 40.58M | 23.8M | 31.91M | 15.8M | 22.35M | 24.85M | 54.36M | 22.02M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 27.83M | 35.59M | 71.32M | 80.4M | 77.7M | 61.79M | 60.69M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 379K | 964K | 1.28M | 2.17M | 2.45M | 2.82M | 1.94M | 2.33M | 2.07M | 2.37M | 303K | 2.09M |
| Total Non-Current Assets | 19.84M | 20.69M | 21.51M | 22.41M | 23.32M | 24.31M | 25.15M | 52.08M | 37.78M | 15.65M | 7.42M | 9.07M |
| Property, Plant & Equipment | 17.84M | 18.7M | 19.52M | 20.42M | 21.33M | 22.32M | 23.16M | 49.41M | 35.28M | 6.8M | 1.98M | 3.83M |
| Fixed Asset Turnover | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.12x | 0.16x | 0.10x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 1.99M | 1.99M | 0 | 1.99M | 0 | 1.39M | 1.39M | 0 | 0 |
| Other Non-Current Assets | 1.99M | 1.99M | 1.99M | 0 | 0 | 1.99M | 0 | 2.67M | 1.11M | 7.46M | 5.44M | 5.24M |
| Total Assets | 36.11M | 43.71M | 52.57M | 56.32M | 66.35M | 78.76M | 94.58M | 141.53M | 142.6M | 120.58M | 125.67M | 93.87M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -45.58% | -44.5% | -44.42% | -60.21% | -53.47% | -34.68% | -24.74% | 50.77% | 29.67% | 0.93% | -3.35% | 98.26% |
| Total Current Liabilities | 9.52M | 9.48M | 11.16M | 11.47M | 12.63M | 14.95M | 19.28M | 18.72M | 19.6M | 19.23M | 14.11M | 14.15M |
| Accounts Payable | 663K | 627K | 680K | 725K | 1.18M | 2.29M | 4.97M | 2.84M | 3.13M | 5.05M | 4.19M | 3.95M |
| Days Payables Outstanding | -197.8 | 601.22 | 319.64 | - | - | - | - | 2K | 4.43K | 34.37 | 34.29 | - |
| Short-Term Debt | 4.82M | 4.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.4M | 0 | 0 |
| Deferred Revenue (Current) | 11.86M | 7K | 32K | 216K | 398K | 607K | 814K | 1.32M | 1.66M | 1.73M | 0 | 1.51M |
| Other Current Liabilities | -7.82M | 4.16M | 3.49M | 4.04M | 4.82M | 4.86M | 3.13M | 0 | 1.23M | 11.05M | 1.5M | 0 |
| Current Ratio | 1.71x | 2.43x | 2.78x | 2.96x | 3.41x | 3.64x | 3.60x | 4.78x | 5.35x | 5.45x | 8.38x | 5.99x |
| Quick Ratio | 1.71x | 2.43x | 2.78x | 2.96x | 3.41x | 3.64x | 3.60x | 4.78x | 5.35x | 5.45x | 8.38x | 5.99x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 37.3M | 38.56M | 39.79M | 40.97M | 42.12M | 43.18M | 44.33M | 45.3M | 33.58M | 17.1M | 12.99M | 13.62M |
| Long-Term Debt | 25.44M | 26.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 27.93M | 29.11M | 30.26M | 31.32M | 32.48M | 33.36M | 21.45M | 4.89M | 0 | 191K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 11.86M | 11.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.99M | 0 |
| Total Liabilities | 46.83M | 48.04M | 50.95M | 52.44M | 54.75M | 58.14M | 63.6M | 64.02M | 53.18M | 36.34M | 27.1M | 27.78M |
| Total Debt | 30.26M | 31.38M | 32.48M | 33.36M | 34.38M | 35.32M | 36.75M | 37.86M | 26.88M | 6.29M | 1.69M | 2.09M |
| Net Debt | 14.37M | 9.32M | 2.69M | 1.62M | -6.2M | 11.52M | 4.84M | 22.06M | 4.53M | -18.56M | -52.67M | -19.93M |
| Debt / Equity | - | - | 20.02x | 8.61x | 2.97x | 1.71x | 1.19x | 0.49x | 0.30x | 0.07x | 0.02x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -10.72M | -4.33M | 1.62M | 3.87M | 11.59M | 20.62M | 30.98M | 77.5M | 89.42M | 84.24M | 98.58M | 66.09M |
| Equity Growth % | -192.44% | -120.99% | -94.76% | -95% | -87.03% | -75.52% | -68.58% | 17.27% | 10.73% | -9.64% | -7.22% | 134.73% |
| Book Value per Share | -0.69 | -2.45 | 1.20 | 0.06 | 0.18 | 0.32 | 0.47 | 1.21 | 1.45 | 1.48 | 2.26 | 1.79 |
| Total Shareholders' Equity | -10.72M | -4.33M | 1.62M | 3.87M | 11.59M | 20.62M | 30.98M | 77.5M | 89.42M | 84.24M | 98.58M | 66.09M |
| Common Stock | 2K | 2K | 2K | 66K | 65K | 65K | 65K | 61K | 57K | 50K | 50K | 32K |
| Retained Earnings | -433.71M | -426.76M | -420.77M | -413.34M | -404.79M | -393.81M | -381.94M | -333.81M | -311.36M | -296.2M | -280.55M | -264.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 20K | -4K | 25K | 33K | -7K | -27K | -12K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |